That's a sorry way of looking at it. This is personalized medicine, showing that understanding biology is the best way to develop a drug. The data is highly impressive.
I'd say data are stellar for G551D mutation carriers, and there's still hope for the F508del mutation carriers that the VX-809/VX-770 combo therapy will work with acceptable safety profile.